Cosmeceutical Ingredients: Botanical and Nonbotanical Sources

  • Renan LageEmail author
  • Cínthia Mendes
  • Beatrice Martinez Zugaib Abdalla
  • Jack Arbiser
  • Adilson Costa
Reference work entry
Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD, volume 1)


Cosmeceuticals are considered to be all products containing biologically active substances and ingredients with beneficial effects on the skin, interfering positively on skin physiology, without therapeutic pretension, but may have preventive effects beyond beautification. Thirty-five percent of US dermatologists already include cosmeceuticals in their prescriptions, and since then cosmeceutical has represented constantly expanding group. In addition, it is certain that it is up to dermatologists to carefully evaluate each patient and the correct indication and need for the use of such substances. Although not individualized in a particular category, according to the American standards defined by the FDA, cosmeceuticals should always be evaluated to have checked their safety and efficacy profiles, since these are created with pharmacologically active substances that must respect certain pharmacokinetic principles, as they reach the deeper layers of the skin.


Cosmetics Antioxidants Retinoids Fatty acids 


  1. Aburjai T, Natsheh FM. Plants in cosmetics. Phytother Res. 2003;19(9):987–1000.CrossRefGoogle Scholar
  2. Afornali A, de Vecchi R, Stuart RM, Dieamant G, de Oliveira LL, Brohem CA, Feferman IHS, Fabricio LHZ, Lorencini M. Triple nanoemulsion potentiates the effects of topical treatments with microencapsulated retinol and modulates biological processes related to skin aging. An Bras Dermatol. 2013;88(6):930–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Almeida IF, Bahia MF. Evaluation of the physical stability of two oleogels. Int J Pharm. 2006;327(1-2):73–7.CrossRefPubMedGoogle Scholar
  4. Atomoros FP. Topical botulinum toxin type A for the treatment of moderate to severe lateral canthal lines: preliminary safety and efficacy results of a blinded, randomized, placebo controlled trial. Summer Academy Meeting of the American Academy of Dermatology; 2009. Abstract P2403.Google Scholar
  5. Babu M, Wells A. Dermal-epidermal communication in wound healing. Wounds. 2001;13:183–9.Google Scholar
  6. Bagatin E. Mecanismos do envelhecimento cutâneo e o papel dos cosmecêuticos. Rev Bras Med. 2009;66(3):5–11.Google Scholar
  7. Balandrin MF, Klocke JA, Wurtele ES, Bollinger WH. Natural plant chemicals: sources of industrial and medical materials. Science. 1985;228(4704):1154–60.CrossRefPubMedGoogle Scholar
  8. Barbosa, Oliveira, Seara. AGEs e complicações diabéticas. Arq Bras Edocrinol Metab. 2008;52(6):940–950.Google Scholar
  9. Barnes H. Handbook of elementary rheology. Aberystwyth: Institute of Non-Newtonian Fluid Mechanisms; 2000.Google Scholar
  10. Barquet AP, Funck APG, Koester LS. Comparação entre alfa-hidroxiácidos e poli-hidroxiácidos na cosmiatria e dermatologia. Rev Bras Farm. 2006;87(3):67–73.Google Scholar
  11. Berardesca E, Cameli N, Cavallotti C, Levy JL, Piérard E, Ambrosi GP. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation. J Cosmet Dermatol. 2008;7(1):8–14.CrossRefPubMedGoogle Scholar
  12. Billmann-Eberwein C, Rippke F, Ruzicka T, Krutmann J. Modulation of atopy patch test reactions by topical treatment of human skin with fatty acids-rich emollient. Skin Pharmacol Appl Skin Physiol. 2002;15:100–4.CrossRefPubMedGoogle Scholar
  13. Bizzo H, Hovell AMC, Rezende CM. Óleos essenciais no Brasil: aspectos gerais, desenvolvimento e perspectivas. Quim Nova. 2009;32(3):588–94.CrossRefGoogle Scholar
  14. Brody HJ. Relevance of cosmeceuticals to the dermatologic surgeon. Dermatol Surg. 2005;31(7):796–8.PubMedGoogle Scholar
  15. Brooks G, Scholzz DB, Parish D, et al. Aging and the future of enzymes in cosmetics. C&T. 1997;112:79–89.Google Scholar
  16. Broughton II G, Janis JE, Attinger CE. The basic science of wound healing. Plast Reconstr Surg. 2006;117:12S–34.CrossRefPubMedGoogle Scholar
  17. Bruce S. Cosmeceuticals for the atenuation of extrinsic and intrinsic dermal aging. J Drug Dermatol. 2008;7:s17–22.Google Scholar
  18. Brummer R. Rheology essentials of cosmetic and food emulsions. Berlin/London: Springer; 2006.Google Scholar
  19. Chung JH, Seo JY, Choi HR, et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol. 2001;117:1218–88.CrossRefPubMedGoogle Scholar
  20. Chung J, Cho S, Kang S. Why does the skin age: intrinsic aging, photo aging and their pathophysiology. In: Rigel DS, Wiess RA, Lim HW, Dover JS, editors. Photo aging. New York: Marcel Dekker; 2004. p. 1–13.Google Scholar
  21. Costa A. Tratado Internacional de Cosmecêuticos. Rio de Janeiro: Guanabara Koogan; 2012.Google Scholar
  22. Daithankar A, Padamwar MN, Pisal SS, et al. Moisturizing efficiency of silk protein hydrolysate: silk fibroin. Indian J Biotechnol. 2005;4:115–21.Google Scholar
  23. Dandy F, William MD. Nutrition and aging skin: sugar and glycation. Clin Dermatol. 2010;28:409–11. Department of Medicine, Section of Dermatology, Dartmouth Medical School, Hanover.Google Scholar
  24. Daniel S, Reto M, Fred Z. Collagen glycation and skin aging. Cosmetics and Toiletries Manufacture Worldwide. Mibelle Ag Cosmetics. 2002;
  25. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol. 2007;257:143–79.CrossRefPubMedGoogle Scholar
  26. Draelos ZD. The cosmeceutical conundrum. J Cosmet Dermatol. 2005;4:149–50.CrossRefPubMedGoogle Scholar
  27. Draelos ZD. Cosmeceuticals. Philadelphia: Elsevier; 2014.Google Scholar
  28. Draelos Z, Yarosh D, Lang G et al. Imporved photoaging with topical DNA repair enzymes. J AM Acad Dermatol. 2009;60. AB2 Abstract P107.Google Scholar
  29. Dryer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest Am Soc Clin Investig. 1993;91:2463–9.CrossRefGoogle Scholar
  30. El-Domyati M, Anntia S, Saleh F, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 2002;11:398–405.CrossRefPubMedGoogle Scholar
  31. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127:514–25.CrossRefPubMedGoogle Scholar
  32. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;4:25–34.CrossRefGoogle Scholar
  33. Florez-White M. Antioxidantes tópicos: su papel en el manejo del fotoenvejecimiento. Más Dermatol. 2013;19:3–4.Google Scholar
  34. Freitas PC. Princípios ativos de origem vegetal. Cosmetics and Toiletries. Set/out 1990;2.Google Scholar
  35. Gaspar LR, Maria Campos PMBG. Rheological behavior and the SPF of sunscreens. Inter J Pharm. 2003;250(1):35–44.CrossRefGoogle Scholar
  36. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009;31:327–45.CrossRefPubMedGoogle Scholar
  37. Graham JA, Kligman AM. Cosmetic therapy for the elderly. J Soc Cosmet Chem. 1984;35:133–45.Google Scholar
  38. Grosicki M, Latacz G, Szopa A, Cukier A, Kieć-Kononowicz K. The study of cellular cytotoxicity of argireline – an anti-aging peptide. Acta Biochim Pol. 2014;61(1):29–32.PubMedGoogle Scholar
  39. Harris RB, Foote JA, Hakim IA, et al. Fatty acid composition of red blood cell membranes and risk of squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2005;14:906–12.CrossRefPubMedGoogle Scholar
  40. Hilling C. Human growth factors as natural healers: current literature and application. Cosmet Toiletries. 2010;125:73–6.Google Scholar
  41. Jones DS, Woolfson AD. Measuring sensory properties of semi-solid products using texture profile analysis. Pharm Manuf Rev. 1997;9:1.Google Scholar
  42. Júnior DSR, Leite GB, Patini JB, Rodrigues-Simioni L, Oshima-Franco Y. Efeitos do dimetilaminoetanol (DMAE) em preparação neuromuscular. Saúde Rev. 2007;9(22):59–68.Google Scholar
  43. Kawada A, Konishi N, Oiso N, Kawara S, Date A. Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide. J Dermatol. 2008;35(10):637–42.CrossRefPubMedGoogle Scholar
  44. Kim EJ, Kim M-K, Jim X-J, Oh J-H, Kim JE, Chung JH. Skin aging and photoaging alter fatty acids composition, including 11,14,17-eicosatrienoic acid, in the epidermis of human skin. J Korean Med Sci. 2010;25:980–3.CrossRefPubMedPubMedCentralGoogle Scholar
  45. Kligman AM. Cosmeceuticals as a third category. Cosmet Toiletries. 1995;133:33–8.Google Scholar
  46. Kligman AM. O que são cosmecêuticos. In: Draelos ZD, Dover JS, editors. Cosmecêuticos. Rio de Janeiro: Elsevier; 2005. p. 1–2.Google Scholar
  47. Laba D. Rheological properties of cosmetics and toiletries. New York: Dekker M; 1993.Google Scholar
  48. Lachman L, Lieberman HA, Kanig JL. Teoria e prática na indústria farmacêutica. Lisboa: Fundação Calouste; 2001.Google Scholar
  49. Leonardi GR, Maria Campos PMBG. Estabilidade de formulações cosméticas. Inter J Pharma Compd. Editora Brasileira. 2001; 3(4):154–6.Google Scholar
  50. Levine IN. Solutions, phase equilibrium, surface chemistry and solids & liquid in “physical chemistry”. New York: McGraw-Hill: 1995.Google Scholar
  51. Liu S, Chen Z, Cai X, Sun Y, Zhao C, Liu F, Liu D. Effects of dimethylaminoethanol and compound amino acid on D-galactose induced skin aging model of rat. Sci World J. 2014;2014:507351.Google Scholar
  52. Lods LM, Dres C, Johnson C, Scholz DB, Brooks GJ. The future of enzymes in cosmetics. Int J Cosmet Sci. 2000;22:85–94.CrossRefPubMedGoogle Scholar
  53. Lupus MP. Cosmeceutical peptides. Dermatol Surg. 2005;31:832–6.Google Scholar
  54. Lupus MP, Cole AL. Peptídeos e proteínas. In: Draelos ZD, editor. Cosmecêuticos. Rio de Janeiro: Elsevier; 2005. p. 145–52.Google Scholar
  55. Lupus MP, Cole AL. Cosmeceutical peptides. Dermatol Ther. 2007;20:343–9.CrossRefGoogle Scholar
  56. Maria Campos PMBG. Desenvolvimento de produtos cosméticos. Cosmet Toiletries (em Português). 2002;289:117–31. Barbosa, Oliveira, Seara. AGEs e complicações diabéticas. Arq Bras Edocrinol Metab. 2008; 52–6.Google Scholar
  57. Mazurowska L, Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. J Cosmet Sci. 2008;59:59–69.PubMedGoogle Scholar
  58. Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther. 2007;20:350–9.CrossRefPubMedGoogle Scholar
  59. Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327–48.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Namjoshi S, Benson HA. Cyclic peptides as potential therapeutic agents for skin disorders. Biopolymers. 2010;94:673–80.CrossRefPubMedGoogle Scholar
  61. Nestor M, Bucay V, Callender V, Cohen JL, Sadick N, Waldorf H. Polypodium leucotomos as an adjunct tratment of pigmentary disorders. J Clin Aesthet Dermatol. 2014;7(3):13–7.PubMedPubMedCentralGoogle Scholar
  62. Oliveira MB, do Prado AH, Bernegossi J, Sato CS, Brunetti IL, Scarpa MV, Leonardi GR, Friberg SE, Chorilli M. Topical application of retynil palmitate-loaded nanotechnology-based drug delivery systems for the treatment of skin aging. Biomed Res Int. 2014;2014:1–7.Google Scholar
  63. Rivers JK. The role of cosmeceuticals in untagging therapy. Skin Therapy Lett. 2008;13:5–9.PubMedGoogle Scholar
  64. Rona C, Vailati F, Berardesca E. The cosmetic treatment of wrinkles. J Cosmet Dermatol. 2004;3:26–34.CrossRefPubMedGoogle Scholar
  65. Rosenblat G, Meretski S, Segal J, Tarshis M, Schroeder A, Zanin-Zhorov A, et al. Polyhydroxylated fatty alcohols derived from avocado suppress inflammatory response and provide non-sunscreen protection against UV-induced damage in skin cells. Arch Dermatol Res. 2011;303(4):239–46.CrossRefPubMedGoogle Scholar
  66. Schmuth M, Ortegon AM, Man MQ, Elias PM, Feingold KR, Stahl A. Differencial expression of fatty acid transport proteins in epidermis and skin appendages. J Invest Dermatol. 2005;125:1174–81.CrossRefPubMedGoogle Scholar
  67. Steenvoorden DO, van Henegouwen GM. The use of endogenous antioxidants to improve photo protection. J Photochem Photobiol B. 1997;4:1–10.CrossRefGoogle Scholar
  68. Tanojo H, Bouwstra JA, Junginger HE, Boddé HE. In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. Pharm Res. 1997;14(1):42–9.CrossRefPubMedGoogle Scholar
  69. Tanojo H, Boelsma E, Junginger HE, Ponec M, Boddé HE. In vivo human skin barrier modulation by topical application of fatty acids. Skin Pharmacol Appl Skin Physyiol. 1998;11:87–97.CrossRefGoogle Scholar
  70. Ulrich P, Cerami A. Protein glycation, diabetes and aging. The Kenneth S. Warren Laboratories, 765 Old Saw Mill River Road, Tarrytown, New York. Copyright 2001 by The Endocrine Society. Download from Scholar
  71. Wagas MK, Akhtar N, Mustafa R, Jamshaid M, Khan HM, Murtaza G. Dermatological and cosmetical benefits of Glycine max (soybean) and its active components. Acta Pol Pharm. 2015;72(1):3–11.Google Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Renan Lage
    • 1
    Email author
  • Cínthia Mendes
    • 1
  • Beatrice Martinez Zugaib Abdalla
    • 2
  • Jack Arbiser
    • 3
  • Adilson Costa
    • 4
  1. 1.Service of Dermatology of the Pontifical Catholic University of Campinas (PUC-Campinas)CampinasBrazil
  2. 2.ABD Foundation School of Medicine (FMABC)Santo AndreBrazil
  3. 3.Department of DermatologyWinship Cancer Institute, Emory University School of Medicine, Atlanta VA Medical CenterAtlantaUSA
  4. 4.Jack Arbiser’s Laboratory, Department of DermatologyEmory University School of MedicineAtlantaUSA

Personalised recommendations